Charles Jacklin - CNO Financial Independent Director
| CNO Stock | USD 25.21 0.21 0.83% |
Director
Mr. Charles J. Jacklin is an Independent Director of CNO Financial Group, Inc. Mr. Jacklin has more than 30 years of finance and investment experience. He served as Chief Executive Officer and President of Mellon Capital Management Corporation from 2006 until March 2011 and then served as Chairman until his retirement at the end of 2012 since 2015.
| Age | 65 |
| Tenure | 9 years |
| Address | 11825 North Pennsylvania Street, Carmel, IN, United States, 46032 |
| Phone | 317 817 6100 |
| Web | https://www.cnoinc.com |
CNO Financial Management Efficiency
The company has Return on Asset of 0.0109 % which means that on every $100 spent on assets, it made $0.0109 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1388 %, implying that it generated $0.1388 on every 100 dollars invested. CNO Financial's management efficiency ratios could be used to measure how well CNO Financial manages its routine affairs as well as how well it operates its assets and liabilities. At this time, CNO Financial's Return On Tangible Assets are very stable compared to the past year. As of the 16th of April 2024, Return On Assets is likely to grow to 0.01, while Return On Capital Employed is likely to drop 0.01. At this time, CNO Financial's Return On Assets are very stable compared to the past year.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Patrick Shouvlin | Brighthouse Financial | 67 | |
| Toshihiko Fukuzawa | Aflac Incorporated | 63 | |
| Melvin Stith | Aflac Incorporated | 74 | |
| Thomas Kenny | Aflac Incorporated | 57 | |
| Katherine Rohrer | Aflac Incorporated | 67 | |
| Diane Offereins | Brighthouse Financial | 60 | |
| Charles Knapp | Aflac Incorporated | 70 | |
| Paul Amos | Aflac Incorporated | 41 | |
| Robert Johnson | Aflac Incorporated | 74 | |
| Barbara Rimer | Aflac Incorporated | 72 | |
| Irene Britt | Brighthouse Financial | 55 | |
| Eileen Mallesch | Brighthouse Financial | 62 | |
| Paul Wetzel | Brighthouse Financial | 58 | |
| Karole Lloyd | Aflac Incorporated | 62 | |
| Joseph Moskowitz | Aflac Incorporated | 67 | |
| Paul Bowers | Aflac Incorporated | 61 | |
| Elizabeth Hudson | Aflac Incorporated | 67 | |
| Takuro Yoshida | Aflac Incorporated | 62 | |
| William Wallace | Brighthouse Financial | 70 | |
| Margaret McCarthy | Brighthouse Financial | 64 | |
| Douglas Johnson | Aflac Incorporated | 73 | |
Management Performance
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0109 |
CNO Financial Group Leadership Team
Elected by the shareholders, the CNO Financial's board of directors comprises two types of representatives: CNO Financial inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CNO. The board's role is to monitor CNO Financial's management team and ensure that shareholders' interests are well served. CNO Financial's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CNO Financial's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Daniel Maurer, Independent Chairman of the Board | ||
| Mary Henderson, Independent Director | ||
| Robert Birty, Vice President - Bankers Life Business | ||
| Robert Yates, Vice President - Distribution Planning | ||
| Gary Bhojwani, President, Chief Executive Officer, Director | ||
| Karen Detoro, Chief Risk Officer, Chief Actuary | ||
| Michael Heard, President of the Worksite Division | ||
| Chetlur Ragavan, Independent Director | ||
| Carrie Jost, Vice President - Communications | ||
| Tricia Borcherding, Vice President - Human Resources | ||
| Christopher Nickele, Chief Actuary and Executive VP | ||
| Dana Allen, Vice President - Product Marketing | ||
| Jill Klibanov, Vice President of Product Management Modeling | ||
| Nancy Sweet, Chief President | ||
| Jeffrey CPA, VP Treasurer | ||
| Steve Liou, Vice President of Health Valuation | ||
| Yvonne Franzese, Chief Human Resource Officer, Executive Vice President | ||
| Rocco Tarasi, Vice President - Finance and Operations | ||
| Ellyn Brown, Independent Director | ||
| WhaNing Doo, Vice President - Annuity Valuation | ||
| Michael Mead, Chief Officer | ||
| Jeanne Linnenbringer, Chief Officer | ||
| Ben Tesnar, VP Officer | ||
| Doug Williams, Vice President of Finance and Administration | ||
| Scott Perry, Chief Bus. Officer | ||
| Rocco III, Chief Officer | ||
| Scott Goldberg, President of Consumer Division | ||
| Frederick Sievert, Independent Director | ||
| Joel Schwartz, President - Colonial Penn Segment | ||
| Charles Jacklin, Independent Director | ||
| Erik Helding, Chief Financial Officer, Executive Vice President | ||
| Edward Bonach, CEO, Director, Member of Executive Committee and Member of Investment Committee | ||
| Adam Auvil, Vice Development | ||
| John Kline, Senior Vice President Chief Accounting Officer | ||
| Steven Shebik, Independent Director | ||
| Michael Tokarz, Independent Director | ||
| Tim Bischof, Chief Risk Officer | ||
| Carolyn ODonnell, Vice President - Organizational Development | ||
| Michael Milos, Vice President - Sales and Distribution Strategy | ||
| Mike Mead, Senior Vice President CIO | ||
| Nathan Richardson, Senior Vice President - Sales and Distribution | ||
| Pat Casey, Chief Technology Officer, Vice President | ||
| Mike Heard, President - Washington National Segment | ||
| Patti Kolodziejczyk, Vice President of Application Delivery | ||
| Susan Menzel, Executive Vice President - Human Resources | ||
| Eric Johnson, Chief Investment Officer, President and Chief Executive Officer of 40|86 Advisors | ||
| Neal Schneider, Non-Executive Chairman of the Board | ||
| Michael Byers, Co-President - Worksite Division | ||
| Patrick Bogan, Vice President - IT Strategy and Operational Excellence | ||
| Michellen Wildin, Senior Officer | ||
| Gerardo Monroy, Chief Marketing Officer | ||
| David Foss, Independent Director | ||
| Matthew Zimpfer, Executive Vice President General Counsel | ||
| Jennifer Childe, Vice President of Investor Relations | ||
| Scott CPA, President Division | ||
| Paul McDonough, Chief Financial Officer | ||
| Robert Greving, Independent Director | ||
| Jeremy Williams, Senior Vice President of Valuation | ||
| Stephen David, Independent Director | ||
| Bruce Baude, Chief Operations and Technology Officer, Executive Vice President | ||
| Zandra Haai, Vice President of Fixed Income Research | ||
| John CPA, VP Officer |
CNO Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CNO Financial a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0109 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 6.8 B | ||||
| Shares Outstanding | 108.64 M | ||||
| Shares Owned By Insiders | 1.89 % | ||||
| Shares Owned By Institutions | 98.14 % | ||||
| Number Of Shares Shorted | 2.26 M | ||||
| Price To Earning | 6.89 X |
Pair Trading with CNO Financial
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CNO Financial position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CNO Financial will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to CNO Financial could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CNO Financial when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CNO Financial - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CNO Financial Group to buy it.
The correlation of CNO Financial is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CNO Financial moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CNO Financial Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CNO Financial can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CNO Financial Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for CNO Stock analysis
When running CNO Financial's price analysis, check to measure CNO Financial's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CNO Financial is operating at the current time. Most of CNO Financial's value examination focuses on studying past and present price action to predict the probability of CNO Financial's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CNO Financial's price. Additionally, you may evaluate how the addition of CNO Financial to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
Is CNO Financial's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CNO Financial. If investors know CNO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CNO Financial listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.04) | Dividend Share 0.59 | Earnings Share 2.4 | Revenue Per Share 36.608 | Quarterly Revenue Growth 0.202 |
The market value of CNO Financial Group is measured differently than its book value, which is the value of CNO that is recorded on the company's balance sheet. Investors also form their own opinion of CNO Financial's value that differs from its market value or its book value, called intrinsic value, which is CNO Financial's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CNO Financial's market value can be influenced by many factors that don't directly affect CNO Financial's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CNO Financial's value and its price as these two are different measures arrived at by different means. Investors typically determine if CNO Financial is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CNO Financial's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.